Clinical Trial Analysis of Different Stages of HBV Patients Treated with Human CIK Cells by Fangfang Xia, Ruihua Song, Jingjing Zhang, Yang Zhu, Yao Yang, Ling He, Yun Cao, Chenlu Li, Zheng Wang, Shangli Cheng, Jian Ni, Lijun Ma, Ding Li, Daxiang Cui

“…Herein, we reported clinical trial results of Cytokine-induced killer (CIK) cells used for patients with hepatitis B, cirrhosis and liver cancers from 2000 to 2015. Results showed CIK cell therapeutic effects were closely positively associated with CIK cell numbers, treated times and HBV genotypes. …”
Get full text

Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View by Maen Abdelrahim, Abdullah Esmail, Ashish Saharia, Ala Abudayyeh, Noha Abdel-Wahab, Adi Diab, Naoka Murakami, Ahmed O. Kaseb, Jenny C. Chang, Ahmed Osama Gaber, Rafik Mark Ghobrial

“…Hepatocellular carcinoma (HCC) represents the second most common cause of cancer-related deaths and accounts for over eighty percent of primary liver cancers worldwide. Surgical resection and radiofrequency ablation in small tumors are included in the treatment options for HCC patients with good liver function profiles. …”
Get full text

Oligosaccharide Ligands of Galectin-4 and Its Subunits: Multivalency Scores Highly by Kristýna Slámová, Jakub Červený, Zuzana Mészáros, Tereza Friede, David Vrbata, Vladimír Křen, Pavla Bojarová

“…Its altered expression in tumor tissue is associated with, for example, colon, colorectal, and liver cancers, and it increases in tumor progression, and metastasis. …”
Get full text

Aflatoxin Contamination of the Milk Supply: A Pakistan Perspective by Naveed Aslam, Peter C. Wynn

“…Aflatoxins can contribute to the causation of liver cancers, immune system disorders, and growth-related issues in children. …”
Get full text

Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? by Kumar Mia, Zhao Xuelian, Wang Xin

“…<p>Abstract</p> <p>Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) are the two major forms of primary liver cancers (PLC), accounting for approximately 90% and 5% respectively. …”
Get full text

A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors by Zhen Li, Weiling Zheng, Zhengyuan Wang, Zhiqiang Zeng, Huiqing Zhan, Caixia Li, Li Zhou, Chuan Yan, Jan M. Spitsbergen, Zhiyuan Gong

“…Cross-species analyses showed that the zebrafish Myc model correlated well with Myc transgenic mouse models for liver cancers. The Myc-induced zebrafish liver tumors also possessed molecular signatures highly similar to human those of hepatocellular carcinoma. …”
Get full text

Small molecule-based promotion of PKCα-mediated β-catenin degradation suppresses the proliferation of CRT-positive cancer cells. by Jungsug Gwak, Jee-Hyun Lee, Young-Hwa Chung, Gyu-Yong Song, Sangtaek Oh

“…Aberrant accumulation of intracellular β-catenin is a well recognized characteristic of several cancers, including prostate, colon, and liver cancers, and is a potential target for development of anticancer therapeutics. …”
Get full text

Association between human immunodeficiency virus type 1 infection and cancer in the black population of Johannesburg and Soweto, South Africa. by Sitas, F, Bezwoda, W, Levin, V, Ruff, P, Kew, M, Hale, M, Carrara, H, Beral, V, Fleming, G, Odes, R, Weaving, A

“…No other cancers, including cervical and liver cancers, showed significantly elevated odds ratios associated with HIV infection.…”

MicroRNA-486-5p and microRNA-486-3p: Multifaceted pleiotropic mediators in oncological and non-oncological conditions by Aisha M. ElKhouly, R.A. Youness, M.Z. Gad

“…Keywords: miR-486-5p, miR-486-3p, long non-coding RNAs, Xist, Lung cancer, Breast cancer, Liver cancer…”
Get full text

A Microfluidic Chip for Detecting Cholangiocarcinoma Cells in Human Bile by Lien-Yu Hung, Nai-Jung Chiang, Wei-Chun Tsai, Chien-Yu Fu, Yu-Chun Wang, Yan-Shen Shan, Gwo-Bin Lee

“…Abstract Cholangiocarcinoma (CCA), a biliary tract malignancy, accounts for 20% of all liver cancers. There are several existing methods for diagnosis of CCA, though they are generally expensive, laborious, and suffer from low detection rates. …”
Get full text

TMBcalc: a computational pipeline for identifying pan-cancer Tumor Mutational Burden gene signatures by Grete Francesca Privitera, Salvatore Alaimo, Anna Caruso, Alfredo Ferro, Stefano Forte, Alfredo Pulvirenti

“…In particular we conducted a comprehensive testing on: (i) 126 samples sourced from the TCGA database; few independent whole-exome sequencing (WES) datasets linked to colon, breast, and liver cancers, all acquired from the EGA and the ICGC Data Portal. …”
Get full text

Multi-Level Seg-Unet Model with Global and Patch-Based X-ray Images for Knee Bone Tumor Detection by Nhu-Tai Do, Sung-Taek Jung, Hyung-Jeong Yang, Soo-Hyung Kim

“…In contrast to the abundance of studies examining brain, lung, and liver cancers, there has been a lack of studies using deep learning to classify and segment knee bone tumors. …”
Get full text

Hepatocyte-targeting and tumor microenvironment-responsive liposomes for enhanced anti-hepatocarcinoma efficacy by Dongliang Cheng, Zhiwei Wen, Hui Chen, Shiyuan Lin, Wei Zhang, Xin Tang, Wei Wu

“…Our findings indicated that PPP-LIP nanocarriers could be a promising tumor-targeted medication delivery strategy for treating liver cancers with elevated MMP2 expression.…”
Get full text

Resveratrol-Mediated Gold-Nanoceria Synthesis as Green Nanomedicine for Phytotherapy of Hepatocellular Carcinoma by Adel Ghorani-Azam, Javad Mottaghipisheh, Mohammad Sadegh Amiri, Mohammad Mashreghi, Alireza Hashemzadeh, Aliakbar Haddad-Mashadrizeh, Fahimeh Nourbakhsh, Mohabat Nadaf, Mohsen Qayoomian, Mohammad Ehsan Taghavizadeh Yazdi, Sara Vitalini, Marcello Iriti

“…To investigate the anticancer activity of the CeO2@Au core-shells, the cytotoxicity of the nanoparticles was investigated against liver cancerous cell lines (HepG2). Conclusions: The results indicated biosynthesized NCs have significant cellular toxicity properties against HepG2 and could be utilized in hepatocarcinoma therapy. …”
Get full text

Nutritional Factors during and after Cancer: Impacts on Survival and Quality of Life by Sébastien Salas, Vanessa Cottet, Laure Dossus, Philippine Fassier, Julie Ginhac, Paule Latino-Martel, Isabelle Romieu, Stéphane Schneider, Bernard Srour, Marina Touillaud, Mathilde Touvier, Raphaëlle Ancellin

“…Therefore, high-risk nutritional conditions can be encountered for certain cancer sites: from the diagnosis and throughout the health care pathways, weight loss (lung and esophageal cancers), malnutrition (lung, esophageal, colorectal, pancreatic, gastric and liver cancers), weight gain (colorectal, breast and kidney cancers) and alcohol consumption (upper aerodigestive cancers) should be monitored; and after cancer treatments, excess weight should be detected (colorectal, breast and kidney cancers). …”
Get full text

Hepatic Arterial Buffer Response in Liver Radioembolization and Potential Use for Improved Cancer Therapy by Stephan Walrand, Michel Hesse, Philippe d’Abadie, François Jamar

“…Liver radioembolization is a treatment option for unresectable liver cancers, performed by infusion of ⁹⁰Y or ¹⁶⁶Ho loaded spheres in the hepatic artery. …”
Get full text

Lysicamine Reduces Protein Kinase B (AKT) Activation and Promotes Necrosis in Anaplastic Thyroid Cancer by Mariana Teixeira Rodrigues, Ana Paula Picaro Michelli, Gustavo Felisola Caso, Paloma Ramos de Oliveira, Dorival Mendes Rodrigues-Junior, Mirian Galliote Morale, Joel Machado Júnior, Karina Ramalho Bortoluci, Rodrigo Esaki Tamura, Tamiris Reissa Cipriano da Silva, Cristiano Raminelli, Eric Chau, Biana Godin, Jamile Calil-Silveira, Ileana G. Sanchez Rubio

“…However, unexplored alternatives based on natural compounds, such as lysicamine, an alkaloid found in plants with established cytotoxicity against breast and liver cancers, offer promise. Therefore, this study aimed to explore the antineoplastic effects of lysicamine in papillary TC (BCPAP) and ATC (HTH83 and KTC-2) cells. …”
Get full text

Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development by Kimberley D. Katleba, Paramita M. Ghosh, Maria Mudryj

“…However, studies on AR expression in non-prostatic malignancies uncovered that AR-SVs are expressed in glioblastoma, breast, salivary, bladder, kidney, and liver cancers, where they have diverse roles in tumorigenesis. …”
Get full text

PRELIMINARY DATA ON FUMONISINS PRESENCE IN PIG LIVER by B. Lugoboni, T Gazzotti, E. Zironi, A. Barbarossa, A. Piva, G. Pagliuca

“…They are suspected risk factors for esophageal and liver cancers, neural tube defects and cardiovascular problems. …”
Get full text

Current Perspectives on the Surgical Management of Perihilar Cholangiocarcinoma by D. Brock Hewitt, Zachary J. Brown, Timothy M. Pawlik

“…Cholangiocarcinoma (CCA) represents nearly 15% of all primary liver cancers and 2% of all cancer-related deaths worldwide. …”
Get full text